Cipla Limited
Climate Impact & Sustainability Data (2014-04 to 2015-03, 2021-04 to 2022-03, 2023-04 to 2024-03)
Reporting Period: 2014-04 to 2015-03
Environmental Metrics
ESG Focus Areas
- Ethical business practices
- Affordable medicines
- Environmental impact minimization
- Community development
Environmental Achievements
- All manufacturing units certified for ISO 14001 (Environmental Management System)
- Zero discharge of waste from all manufacturing facilities due to effluent treatment plants
- Over 50% of materials procured from local suppliers, reducing transportation costs and emissions
- Approximately 20% of solvents recycled and reused
Social Achievements
- Price cuts up to 76% on three major anti-cancer drugs
- Affordable pricing of iron chelators
- Launch of Trioday, a cost-effective triple-drug antiretroviral combination
- Training programs for teenage students on various life skills (806 sessions in 16 schools, covering about 8500 students)
- Free palliative care services to cancer patients through Cipla Palliative Care and Training Centre
Governance Achievements
- Adoption of a Business Code of Conduct promoting ethical, responsible, and transparent business practices
- Implementation of a Vigil Policy to address unethical behavior and fraud
- Regular monitoring and review of BR performance by the CEO
- Cipla's Corporate Responsibility Policy is based on the National Voluntary Guidelines on Social, Environmental and Economical Responsibilities of Business
Climate Goals & Targets
Environmental Challenges
- Determining product-wise resource consumption due to a multi-product, multi-facility production system
- Addressing stakeholder concerns and managing expectations
Mitigation Strategies
- Ongoing review of product affordability
- Continuous stakeholder engagement through customized mechanisms
- Adoption of world-class environmental and social practices at manufacturing locations
- Use of best-in-class technology for pollution abatement
Supply Chain Management
Responsible Procurement
- Encouraging and supporting local suppliers
Climate-Related Risks & Opportunities
Reporting Standards
Frameworks Used: National Voluntary Guidelines on Social, Environmental and Economic Responsibilities of Business (NVG-SEE)
Certifications: ISO 14001, OHSAS 18001
Reporting Period: 2021-04 to 2022-03
Environmental Metrics
ESG Focus Areas
- Environmental
- Social
- Governance
Environmental Achievements
- Reduced Scope 1 and Scope 2 emissions by 16% compared to FY 2020-21
- 100% equivalent amount of plastic waste collected through waste management agency and co-processed, recycled and/or converted to energy.
- 84% of hazardous waste channeled for recycling, co-processing; 6% disposed to secured landfill.
- All API manufacturing sites located in India and formulations manufacturing site located in Sikkim are zero liquid discharge sites.
Social Achievements
- Various training and awareness programs for employees on topics such as ESG parameters and targets, corporate governance practices, employee well-being, innovation and R&D and various other regulatory updates.
- Implemented measures for employee well-being (details on page 78 of Human Capital)
- Implemented mechanisms to receive and redress grievances for employees and workers (details on page 79 of Human Capital)
Governance Achievements
- Anti-corruption and anti-bribery policy implemented (link provided in report)
- Conflict of Interest Policy and Policy on Related Party Transactions in place (links provided in report)
- Stakeholder Relationship Committee responsible for reviewing ESG/sustainability matters
Climate Goals & Targets
- Not disclosed
- Not disclosed
- Carbon Neutral by 2025
Environmental Challenges
- Scope 3 emissions data not available
- No LCA conducted for products
Mitigation Strategies
- Initiated processes for collating Scope 3 emissions data for FY 2022-23
- Endeavors to conduct LCA for select products in FY 2022-23
Supply Chain Management
Supplier Audits: Null (details on page 90 of Relationship Capital)
Responsible Procurement
- Sustainability Policy and Code of Conduct
- Assessment of suppliers based on ESG parameters
- Capacity building workshops for critical suppliers
Climate-Related Risks & Opportunities
Physical Risks
- Not disclosed
Transition Risks
- Not disclosed
Opportunities
- Not disclosed
Reporting Standards
Frameworks Used: GRI
Certifications: ISO 14001:2015 (all manufacturing sites in India), ISO 45001:2018 (all manufacturing sites in India)
Third-party Assurance: DNV Business Assurance India Private Limited
UN Sustainable Development Goals
- Not disclosed
Not disclosed
Sustainable Products & Innovation
- Not disclosed
Awards & Recognition
- Not disclosed
Reporting Period: 2023-04 to 2024-03
Environmental Metrics
ESG Focus Areas
- Environmental Sustainability
- Product Quality and Safety
- Supply Chain Disruptions
- Availability and Affordability of medicines
- Corporate Governance
Environmental Achievements
- Goa manufacturing sites achieved Zero Waste to Landfill certification.
- 33.6% renewable energy sourced in India manufacturing operations.
- 1.6% reduction in water withdrawn compared to FY 2022-23 in India manufacturing operations.
- 48% water recycled of total water withdrawn in India manufacturing operations.
- Reduced absolute Scope 1 & 2 emissions by 28% compared to baseline.
Social Achievements
- Launched Tuffies campaign to improve respiratory care among children.
- Breathefree counselled more than 36 lac patients in FY 2023-24.
- Cipla Foundation distributed 4,57,292 medicine parcels to patients in FY 2023-24.
- Patient assistance programs helped 20,464 patients gain access to Cipla medications.
Governance Achievements
- 58% of directors are independent.
- Average board meeting attendance was 96.2%.
- Robust risk management framework implemented.
- Zero instances of corruption and bribery reported.
Climate Goals & Targets
- Not disclosed
- Not disclosed
- Carbon neutrality, water neutrality, zero waste to landfill for India manufacturing operations by December 2025.
- 50% renewable electricity in India manufacturing operations by December 2025.
Environmental Challenges
- Supply chain disruptions.
- Climate change impacts (water stress, carbon pricing).
- Regulatory changes in pharmaceutical industry.
- Misuse of Artificial Intelligence.
- Potential for human rights violations in supply chain.
Mitigation Strategies
- Continuous Improvement Programme for supply chain optimization.
- Investments in renewable energy and energy efficiency initiatives.
- Framework for ongoing monitoring and compliance with regulations.
- Robust ISMS policies and guidelines for data privacy and cybersecurity.
- Due diligence process for business agreements and supplier ESG program.
Supply Chain Management
Supplier Audits: 225 audits conducted (desk-based and on-site)
Responsible Procurement
- Supplier Code of Conduct
- Responsible Sourcing Policy
- ESG assessment framework for vendors.
Climate-Related Risks & Opportunities
Physical Risks
- Water stress
Transition Risks
- Carbon pricing
Opportunities
- Increased renewable energy consumption
Reporting Standards
Frameworks Used: DJSI, TCFD, TNFD, GHG Protocol
Certifications: ISO 14001, ISO 45001, ISO 27001, ISO 50001:2018, ISO 14067, ISO 14040/44
Third-party Assurance: DNV Business Assurance India
UN Sustainable Development Goals
- Not disclosed
Not disclosed
Sustainable Products & Innovation
- Low carbon emission inhalers
Awards & Recognition
- Not disclosed